TIVIC HEALTH SYSTEMS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.04 USD | -2.80% |
|
-6.31% | -42.22% |
| Mar. 25 | Transcript : Tivic Health Systems, Inc., 2023 Earnings Call, Mar 25, 2024 | |
| Mar. 25 | Tivic Health Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Presentation Operator MessageOperator (Operator)Welcome to the Tivic Health Systems Second Qua...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Tivic Health Systems, Inc. is a commercial-stage health tech company advancing the field of bioelectronic medicine. The Companyâs patented technology platform leverages stimulation on the trigeminal, sympathetic, and vagus nerve structures. Its non-invasive and targeted approach to the treatment of inflammatory chronic health conditions is intended to give consumers and providers drug-free therapeutic solutions with high safety profiles, low risk, and broad applications. The Companyâs first commercial product, ClearUP, is an FDA approved handheld bioelectronic sinus device. ClearUP is clinically proven, doctor-recommended, and available through online retailers and commercial distributors. ClearUP is sold in the U.S. directly to consumers on various platforms and through reseller channels. The Company is also focused on its intellectual property (IP) portfolio and research programs related to vagus nerve stimulation to expand its applications in non-invasive bioelectronic medicine.
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -42.22% | 1.52M | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
- Stock Market
- Equities
- TIVC Stock
- News Tivic Health Systems, Inc.
- Transcript : Tivic Health Systems, Inc., Q2 2023 Earnings Call, Aug 14, 2023
